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Cartilage compositional magnetic resonance imaging (MRI) techniques are sensitive to changes 1 
in the composition of the extracellular matrix of articular cartilage. Their promise lies in the 2 
potential to detect the earliest stages of cartilage degeneration, at a stage where these changes 3 
may still be reversible. This is a considerable advantage over conventional (structural) MRI; 4 
even with the high spatial-resolution imaging offered by modern high-field (3T) MRI systems, by 5 
the time structural cartilage damage is apparent, there is (by definition) damage to the collagen 6 
matrix implying that the changes are probably already irreversible
1
.  7 
 8 
A wide variety of cartilage compositional MRI techniques have been described over the past 9 
three decades (Table 1). The most widely used of these is T2 (transversal relaxation time) 10 
mapping, which is now available as a product (i.e., commercially available) pulse sequence from 11 
all three major MRI vendors (GE, Siemens and Phillips). T1ρ
 
(longitudinal relaxation time in the 12 
presence of a radiofrequency field) mapping is an alternative which may offer improved 13 
dynamic range to T2 mapping but is not widely available (typically requiring a research 14 
agreement to be in place with the MRI vendor). Both T2 and T1ρ have considerable advantages 15 
over other cartilage compositional techniques making them the most amenable to widespread 16 
use. They do not require the administration of contrast agent, unlike delayed gadolinium 17 
enhanced MRI of cartilage (dGEMRIC), do not require specialist hardware, unlike sodium 18 
imaging, and are feasible at clinically accessible field strengths (i.e., 1.5 or 3 Tesla), unlike 19 
sodium imaging and glycosaminoglycan chemical exchange saturation transfer (gagCEST). The 20 
trade-off is that T2 and T1ρ
 
do not have the same tissue specificity as some of these other 21 











. However, when performed correctly, they have been shown to be able to distinguish 1 
between patients with or at risk of OA from healthy controls and predict development and 2 
progression of OA (Figure 1)
3–5
. They may also offer considerably improved sensitivity to change 3 




[FIGURE 1]  6 
[TABLE 1] 7 
 8 
Despite the clear promise of T2 and T1ρ mapping, both technical and clinical issues have 9 
hindered the widespread uptake of these techniques. Both techniques were introduced more 10 
than 20 years ago but there have been several obstacles to clinical use and acceptance by the 11 
community. From a technical point of view, there is a lack of standardization of acquisition 12 
protocols across different sites and vendors, with a wide variety of sequences available which 13 
may or may not be commercially available. It is therefore little surprise that multi-vendor 14 
reproducibility has previously been reported as suboptimal
8
. Linked to this, in many previous 15 
studies there has been wide variance in selection of sequence parameters and a lack of 16 
understanding of the effect of signal-to-noise ratio (SNR) on data quality. This has led to poorly 17 
executed studies and thus inconclusive or difficult to interpret results. From a clinical point of 18 
view, there is no established threshold for what constitutes a normal vs abnormal value of T2 19 
orT1ρ – nor is there likely to be, given the well-characterized variation between healthy 20 
individuals and within the same individual across different cartilage subregions. Although 21 









cohorts and Z-scores, in our opinion the real clinical utility of these methods is likely to be the 1 
assessment of change within an individual over time and particularly in monitoring the earliest 2 
disease stages that are likely to be the ones most amenable to non-surgical therapy
9,10
. 3 
Ultimately, clinical utility is also limited by the lack of demonstrable effect on patient 4 
management, although there may be exceptions to this (e.g. suitability for and follow-up of 5 
focal cartilage repair treatments such as autologous chondrocyte implantation) and this is a 6 
limitation applicable to all advanced imaging of OA. 7 
 8 
The article in the present issue by Kim and colleagues
14
 represents an important step in 9 
addressing the suboptimal multi-site reproducibility of T2 and T1ρ
 
mapping. The key innovation 10 
is the implementation of the same pulse sequence structure (3D magnetization-prepared angle-11 
modulated partitioned k-space spoiled gradient echo snapshots, or MAPSS) across all three 12 
major MRI vendor platforms. This vendor-neutrality is a significant advance over previous multi-13 
site standardization efforts which have used vendor-specific pulse sequences (Table 2). They 14 
demonstrate excellent intra-site repeatability for both T2 and T1ρ, in agreement with previous 15 
studies and confirming the ability of these methods to detect relatively small longitudinal 16 
changes in this setting
.
 Inter-site reproducibility was not as good (as would be expected), but as 17 
mentioned above the utility of these methods is likely to be for the detection of longitudinal 18 
changes. Therefore, intra-site repeatability is of most interest, assuming an individual is imaged 19 
on the same platform at baseline and follow-up visits. As alluded to above, interpretability of 20 
many existent studies using T2 and T1ρ
 
is limited by the lack of acquisition and analysis expertise. 21 









SNR and suboptimal parameter selection. The contribution of this study in providing a 1 
reproducible set of parameters suitable to generate images of sufficient quality for valid 2 
cartilage T2 and T1ρ
 
quantification across all major MRI vendor platforms is therefore to be 3 
welcomed. An important extension of the current work would be an evaluation of inter-site and 4 
inter-vendor variability of longitudinal changes in T2 and T1ρ.  5 
 6 
[TABLE 2] 7 
 8 
This work builds on existing efforts by the authors and others to develop T2 and T1ρ as 9 
quantitative imaging biomarkers suitable for use in clinical trials and clinical practice. It provides 10 
further evidence of the excellent intra-site repeatability of these methods and highlights the 11 
challenges associated with multi-site and multi-vendor implementation. The Quantitative 12 
Imaging Biomarkers Alliance (QIBA), an initiative endorsed by the Radiologic Society of North 13 
America (RSNA) with the aim to foster collaboration to identify needs, barriers and solutions to 14 
create consistent, reliable, valid and achievable quantitative imaging results across imaging 15 
platforms, clinical sites, and timepoints, recently published a statement regarding the 16 
application of compositional MRI in degenerative joint disease 17 
(https://qibawiki.rsna.org/images/2/20/QIBA_Profile_MSK-Cartilage-Stage1_Profile.pdf).  QIBA 18 
aims to promote quantitative imaging in clinical trials and clinical practice, with profile 19 
statements to improve method standardization. As part of this, options for accessing the 3D 20 









profile is open for public comment through 29 September 2020 and we would encourage any 1 
interested party to review and contribute. 2 
 3 
What does all this mean for the general OA researcher? First, there are  ongoing international 4 
efforts to improve the accessibility and utility of  T2 and T1ρ to non-imaging specialist 5 
researchers. This involves work both on standardization of image acquisition (exemplified by 6 
the work of Kim and colleagues in this issue) but also on standardization of image analysis. The 7 
latter often involves automated approaches built on AI algorithms which should reduce time 8 
burden taken for analysis (particularly segmentation), improve integration into clinical 9 
workflow and reduce variability associated with the use of different analysis pipelines
11,12
. 10 
Second, the pathway to routine clinical use of T2 and T1ρ for cartilage assessment in OA cannot 11 
be followed by the imaging community alone; technical validation and improvement in data 12 
quality must be accompanied by clinical validation (demonstration of how is patient care 13 
influenced, for example assisting clinicians in assessing response to therapy) and demonstration 14 
of cost effectiveness in order to achieve clinical translation
13
. Therefore, in order for the 15 
potential of these powerful techniques to be realized, it will be important to have support from 16 
the wider OA research community. 17 
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Figure legends 1 
Figure 1. T1ρ mapping predicts onset of focal morphological cartilage lesions. T1ρ mapping 2 
overlaid on morphological MRI (3D fat-suppressed spoiled gradient echo) of patient undergoing 3 
arthroscopic meniscectomy, performed pre-procedure (A) and at 6 months (B) and 1 year (C) 4 
follow-up. Note development of focal region of elevated T1ρ (single arrow) at 6 months which 5 
develops into an area of more diffuse partial thickness loss (double arrows) at 1 year (1 year 6 









Table 1. Overview of commonly used cartilage compositional MRI techniques 
Technique Cartilage component 
assessed 
Pros Cons 
T2 mapping Collagen orientation, 
collagen content, water 
content 
Easily accessible 






T1ρ mapping Macromolecular content, 
water content 
Improved dynamic 
range c.f. T2 
Feasible at 3T 
Not readily available 
Similar information 
to T2 at clinically 
feasible spin-lock 
frequencies 
T2* mapping Collagen orientation, 
collagen content, water 
content 
Potentially faster 
acquisition c.f. T2 
Can be combined with 
UTE imaging to assess 
deepest layers of 
cartilage 
Feasible at 3T 
Similar information 














gagCEST GAG GAG specificity Currently not feasible 
at < 7T 






spatial resolution & 
SNR with standard 
DWI sequences 
Abbreviations: UTE – ultrashort echo time, GAG – glycosaminoglycan, DWI – diffusion-weighted 








Table 2. Comparison of standard T2 and T1ρ MRI and MAPSS pulse sequence 
Drawbacks of commercially available pulse 
sequence (i.e., spin echo-based) 
Advantage conferred by MAPSS pulse 
sequence 
Slow readout so TEs not optimized for 
cartilage, TE dependent on hardware 
considerations 
Magnetization prepared so TE can be short, 
optimized for cartilage and standardized 
First TE often has to be discarded due to 
stimulated echo effects 
Stimulated echo not an issue as T2/T1p 
magnetization preparation is utilized 
 
Poor SNR efficiency, often 2D readout - so 
spatial resolution limited 
3D readout with improved SNR efficiency 
Multiple vendor-specific implementations Single implementation available across 
multiple vendors 
Abbreviations: SNR – signal-to-noise ratio, TE – echo time 
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